Estrogen activates matrix metalloproteinases-2 and -9 to increase beta amyloid degradation

Molecular and Cellular Neuroscience

Volumn 49, Issue 4, 2012, Pages 423-429

  Merlo, Sara ^a   Sortino, Maria Angela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Amyloid peptide; 17 Estradiol; Alzheimer's disease; Matrix metalloproteinases

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GELATINASE A; GELATINASE B; ILOMASTAT; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SPECIFICITY; GLIOMA CELL; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROVOCATION TEST;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BLOTTING, WESTERN; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; ESTROGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEURONS; NEUROPROTECTIVE AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84858719450     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2012.02.005     Document Type: Article

References (60)

1. Amtul Z., Wang L., Westaway D., Rozmahel R.F. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease. Neuroscience 2010, 169:781-786.
2. Asahina M., Yoshiyama Y., Hattori T. Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clin. Neuropathol. 2001, 20:60-63.
3. Backstrom J.R., Lim G.P., Cullen M.J., Tokes Z.A. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J. Neurosci. 1996, 16:7910-7919.
4. Baig S., Kehoe P.G., Love S. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 2008, 34:205-215.
5. Bharadwaj P.R., Dubey A.K., Masters C.L., Martins R.N., Macreadie I.G. Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. J. Cell. Mol. Med. 2009, 13:412-421.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
7. Braundmeier A.G., Fazleabas A.T., Nowak R.A. Extracellular matrix metalloproteinase inducer expression in the baboon endometrium: menstrual cycle and endometriosis. Reproduction 2010, 140:911-920.
8. Chambaut-Guerin A.M., Herigault S., Rouet-Benzineb P., Rouher C., Lafuma C. Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: relevance to neuronal differentiation. J. Neurochem. 2000, 74:508-517.
9. Correia S.C., Santos R.X., Cardoso S., Carvalho C., Santos M.S., Oliveira C.R., Moreira P.I. Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?. Curr. Aging Sci. 2010, 3:113-126.
10. Crowe D.L., Brown T.N. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion. Neoplasia 1999, 1:368-372.
11. Curran S., Murray G.I. Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 1999, 189:300-308.
12. De Strooper B. Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol. Rev. 2010, 90:465-494.
13. Eckman E.A., Eckman C.B. Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. Biochem. Soc. Trans. 2005, 33:1101-1105.
14. Fisher K.E., Fei Q., Laird E.R., Stock J.L., Allen M.R., Sahagan B.G., Strick C.A. Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brain. Biochemistry 2002, 41:8289-8297.
15. Gilliver S.C., Emmerson E., Campbell L., Chambon P., Hardman M.J., Ashcroft G.S. 17beta-estradiol inhibits wound healing in male mice via estrogen receptor-alpha. Am. J. Pathol. 2010, 176:2707-2721.
16. Guccione M., Silbiger S., Lei J., Neugarten J. Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am. J. Physiol. Renal. Physiol. 2002, 282:F164-F169.
17. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
18. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry 1999, 38:8972-8980.
19. Horstmann S., Budig L., Gardner H., Koziol J., Deuschle M., Schilling C., Wagner S. Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease. Int. Psychogeriatr. 2010, 22:966-972.
20. Hu X., Crick S.L., Bu G., Frieden C., Pappu R.V., Lee J.M. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20324-20329.
21. Leissring M.A. Proteolytic degradation of the amyloid beta-protein: the forgotten side of Alzheimer's disease. Curr. Alzheimer Res. 2006, 3:431-435.
22. Liang K., Yang L., Yin C., Xiao Z., Zhang J., Liu Y., Huang J. Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin. J. Biol. Chem. 2010, 285:935-942.
23. Lomakin A., Teplow D.B., Kirschner D.A., Benedek G.B. Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:7942-7947.
24. Lu T., Achari Y., Sciore P., Hart D.A. Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site. Biochim. Biophys. Acta 2006, 1762:719-731.
25. Marin-Castano M.E., Elliot S.J., Potier M., Karl M., Striker L.J., Striker G.E., Csaky K.G., Cousins S.W. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2003, 44:50-59.
26. Miners J.S., Baig S., Palmer J., Palmer L.E., Kehoe P.G., Love S. Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol. 2008, 18:240-252.
27. Mohamed A., Posse de Chaves E. Abeta internalization by neurons and glia. Int. J. Alzheimers Dis. 2011, 2011:127984.
28. Munaut C., Noel A., Hougrand O., Foidart J.M., Boniver J., Deprez M. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int. J. Cancer 2003, 106:848-855.
29. Nagase H., Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 1999, 274:21491-21494.
30. Nalivaeva N.N., Fisk L.R., Belyaev N.D., Turner A.J. Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 2008, 5:212-224.
31. Nord L.C., Sundqvist J., Andersson E., Fried G. Analysis of oestrogen regulation of alpha-, beta- and gamma-secretase gene and protein expression in cultured human neuronal and glial cells. Neurodegener. Dis. 2010, 7:349-364.
32. Ould-yahoui A., Tremblay E., Sbai O., Ferhat L., Bernard A., Charrat E., Gueye Y., Lim N.H., Brew K., Risso J.J., Dive V., Khrestchatisky M., Rivera S. A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons. PLoS One 2009, 4:e8289.
33. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 2007, 8:221-233.
34. Pike C.J., Carroll J.C., Rosario E.R., Barron A.M. Protective actions of sex steroid hormones in Alzheimer's disease. Front. Neuroendocrinol. 2009, 30:239-258.
35. Potier M., Elliot S.J., Tack I., Lenz O., Striker G.E., Striker L.J., Karl M. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J. Am. Soc. Nephrol. 2001, 12:241-251.
36. Roher A.E., Kasunic T.C., Woods A.S., Cotter R.J., Ball M.J., Fridman R. Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A. Biochem. Biophys. Res. Commun. 1994, 205:1755-1761.
37. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 2002, 39:279-291.
38. Saido T.C. Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid. Neurobiol. Aging 1998, 19:S69-S75.
39. Saito T., Takaki Y., Iwata N., Trojanowski J., Saido T.C. Alzheimer's disease, neuropeptides, neuropeptidase, and amyloid-beta peptide metabolism. Sci. Aging Knowledge Environ. 2003, PE1.
40. Salonurmi T., Parikka M., Kontusaari S., Pirila E., Munaut C., Salo T., Tryggvason K. Overexpression of TIMP-1 under the MMP-9 promoter interferes with wound healing in transgenic mice. Cell Tissue Res. 2004, 315:27-37.
41. Santos F.C., Rochel-Maia S.S., Fochi R.A., Justulin L.A., Santos S.A., Vilamaior P.S., Felisbino S.L., Goes R.M., Taboga S.R. MMP-2 and MMP-9 localization and activity in the female prostate during estrous cycle. Gen. Comp. Endocrinol. 2011, 173:419-427.
42. Sbai O., Ferhat L., Bernard A., Gueye Y., Ould-Yahoui A., Thiolloy S., Charrat E., Charton G., Tremblay E., Risso J.J., Chauvin J.P., Arsanto J.P., Rivera S., Khrestchatisky M. Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Mol. Cell. Neurosci. 2008, 39:549-568.
43. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N. Y. Acad. Sci. 2000, 924:17-25.
44. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289:2651-2662.
45. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol. 2003, 200:448-464.
46. Takamura A., Okamoto Y., Kawarabayashi T., Yokoseki T., Shibata M., Mouri A., Nabeshima T., Sun H., Abe K., Urisu T., Yamamoto N., Shoji M., Yanagisawa K., Michikawa M., Matsubara E. Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse. Mol. Neurodegener. 2011, 6:20.
47. Turner A.J., Nalivaeva N.N. New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection. Int. Rev. Neurobiol. 2007, 82:113-135.
48. Turner A.J., Fisk L., Nalivaeva N.N. Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration. Ann. N. Y. Acad. Sci. 2004, 1035:1-20.
49. Vassilev V., Pretto C.M., Cornet P.B., Delvaux D., Eeckhout Y., Courtoy P.J., Marbaix E., Henriet P. Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo. J. Clin. Endocrinol. Metab. 2005, 90:5848-5857.
50. Voloshenyuk T.G., Gardner J.D. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R683-R693.
51. Walsh D.M., Selkoe D.J. A beta oligomers - a decade of discovery. J. Neurochem. 2007, 101:1172-1184.
52. Wang K.C., Lin Y.F., Qin C.H., Chen T.L., Chen C.H. Bisphenol-A interferes with estradiol-mediated protection in osteoarthritic chondrocytes. Toxicol. Lett. 2010, 198:127-133.
53. Wingrove C.S., Garr E., Godsland I.F., Stevenson J.C. 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim. Biophys. Acta 1998, 1406:169-174.
54. Xu H., Wang R., Zhang Y.W., Zhang X. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease. Ann. N. Y. Acad. Sci. 2006, 1089:324-342.
55. Yin K.J., Cirrito J.R., Yan P., Hu X., Xiao Q., Pan X., Bateman R., Song H., Hsu F.F., Turk J., Xu J., Hsu C.Y., Mills J.C., Holtzman D.M., Lee J.M. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J. Neurosci. 2006, 26:10939-10948.
56. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 2005, 6:931-944.
57. Yu L., Wang C.Y., Shi J., Miao L., Du X., Mayer D., Zhang J. Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells. Endocrinology 2011, 152:773-781.
58. Zhang Y., Stewart K.G., Davidge S.T. Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries. Hypertension 2000, 36:970-974.
59. Zhao L., Yao J., Mao Z., Chen S., Wang Y., Brinton R.D. 17beta-Estradiol regulates insulin-degrading enzyme expression via an ERbeta/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobio.l Aging 2011, 32:1949-1963.
60. Zhu H., Zheng J., Xiao X., Zheng S., Dong K., Liu J., Wang Y. Environmental endocrine disruptors promote invasion and metastasis of SK-N-SH human neuroblastoma cells. Oncol. rep. 2010, 23:129-139.